KE 
Kempen
Price targets from Kempen
Bioinvent
Upside
+254.77%Target
80.00 SEKDate
May 28
SLP
Upside
+14.44%Target
42.00 SEKDate
Mar 30
Sagax
Upside
+3.98%Target
170.00 SEKDate
Mar 30
Hufvudstaden
Upside
+8.15%Target
130.00 SEKDate
Jan 13
Wihlborgs
Upside
+25.00%Target
95.00 SEKDate
Jan 13
Balder
Upside
+40.00%Target
70.00 SEKDate
Jan 13
Atrium Ljungberg
Upside
+16.98%Target
31.00 SEKDate
Jan 13
Camurus
Upside
+50.55%Target
950.00 SEKDate
Sep 11 '25
Cantargia
Upside
+325.53%Target
8.00 SEKDate
Aug 27 '25
Bavarian Nordic
Upside
+29.44%Target
233.00 SEKDate
Aug 27 '25
Egetis Therapeutics
Upside
+80.18%Target
12.00 SEKDate
Aug 8 '25
Entra
Upside
+19.05%Target
125.00 SEKDate
Aug 4 '25
Catena
Upside
+27.68%Target
500.00 SEKDate
Jul 14 '25
Gubra
Upside
+111.19%Target
740.00 SEKDate
Jun 27 '25
Zealand Pharma
Upside
+53.43%Target
450.00 SEKDate
Jun 27 '25
Rockwool
Upside
+34.72%Target
260.00 SEKDate
Jun 18 '25
Castellum
Upside
+0.50%Target
130.00 SEKDate
Apr 24 '25
Bioarctic
Upside
+13.64%Target
350.00 SEKDate
Nov 27 '23
Biovica
Upside
+6085.57%Target
30.00 SEKDate
Jun 16 '23
Fabege
Upside
+1.69%Target
75.00 SEKDate
Apr 6 '23
SBB
Upside
+254.50%Target
11.00 SEKDate
Apr 6 '23
Vicore Pharma
Upside
+252.11%Target
40.00 SEKDate
Mar 29 '23
Oncopeptides
Upside
+2034.15%Target
35.00 SEKDate
Jul 5 '22
Calliditas
Upside
+53.85%Target
320.00 SEKDate
Dec 16 '21
Kungsleden
Upside
+7.35%Target
130.00 SEKDate
Sep 6 '21
Synact Pharma
Upside
+555.14%Target
125.00 SEKDate
Jun 28 '21
Xbrane Biopharma
Upside
+1700.00%Target
180.00 SEKDate
Jun 2 '21